Differential in vitro and cellular effects of iron chelators for hypoxia inducible factor hydroxylases

Journal of Cellular Biochemistry

Volumn 114, Issue 4, 2013, Pages 864-873

  Cho, Eun A ^a,b   Song, Hyun Kyung ^a,c   Lee, Sang Hyeup ^d   Chung, Bong Hyun ^a,c   Lim, Heon Man ^b   Lee, Myung Kyu ^a,c  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Chungnam National University   (South Korea)

^c University of Science and Technology (UST)   (South Korea)

^d Catholic University of Daegu   (South Korea)

Author keywords

HIF HYDROXYLASES; HYDROXYLASE INHIBITION; HYPOXIA INDUCIBLE FACTOR; IRON CHELATORS

Indexed keywords

CATECHOL METHYLTRANSFERASE; FERRIC ION; HYDROXYL GROUP; HYPOXIA INDUCIBLE FACTOR; IRON CHELATING AGENT; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; QUERCETIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; ENZYME INHIBITION; HYDROXYLATION; IN VITRO STUDY; IRON CHELATION; IRON DEPLETION; MEMBRANE PERMEABILITY; METHYLATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANOXIA; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; CELL MEMBRANE PERMEABILITY; CLONING, MOLECULAR; ENZYME ACTIVATION; ENZYME INHIBITORS; FERRIC COMPOUNDS; HELA CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; HYPOXIA-INDUCIBLE FACTOR-PROLINE DIOXYGENASES; IRON; IRON CHELATING AGENTS; MICE; MICE, INBRED BALB C; MIXED FUNCTION OXYGENASES; PHENANTHROLINES; PROCOLLAGEN-PROLINE DIOXYGENASE; PROTEIN BINDING; QUERCETIN; REPRESSOR PROTEINS; TRANSCRIPTION, GENETIC;

EID: 84874266886     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24423     Document Type: Article

References (29)

1. Chowdhury R, McDonough MA, Mecinovic J, Loenarz C, Flashman E, Hewitson KS, Domene C, Schofield CJ,. 2009. Structural basis for binding of hypoxia-inducible factor to the oxygen-sensing prolyl hydroxylases. Structure 17: 981-989.
2. Cornish KM, Williamson G, Sanderson J,. 2002. Quercetin metabolism in the lens: Role in inhibition of hydrogen peroxide induced cataract. Free Radic Biol Med 33: 63-70.
3. Dayan F, Roux D, Brahimi-Horn MC, Pouyssegur J, Mazure NM,. 2006. The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1alpha. Cancer Res 66: 3688-3698.
4. De Domenico I, Ward DM, Kaplan J,. 2009. Specific iron chelators determine the route of ferritin degradation. Blood 114: 4546-4551.
5. Graf BA, Milbury PE, Blumberg JB,. 2005. Flavonols, flavones, flavanones, and human health: Epidemiological evidence. J Med Food 8: 281-290.
6. Hewitson KS, McNeill LA, Riordan MV, Tian YM, Bullock AN, Welford RW, Elkins JM, Oldham NJ, Bhattacharya S, Gleadle JM, Ratcliffe PJ, Pugh CW, Schofield CJ,. 2002. Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. J Biol Chem 277: 26351-26355.
7. Ivan M, Haberberger T, Gervasi DC, Michelson KS, Gunzler V, Kondo K, Yang H, Sorokina I, Conaway RC, Conaway JW, Kaelin WG, Jr., 2002. Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor. Proc Natl Acad Sci USA 99: 13459-13464.
8. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, Kriegsheim A, Hebestreit HF, Mukherji M, Schofield CJ, Maxwell PH, Pugh CW, Ratcliffe PJ,. 2001. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292: 468-472.
9. Jeon H, Kim H, Choi D, Kim D, Park SY, Kim YJ, Kim YM, Jung Y,. 2007. Quercetin activates an angiogenic pathway, hypoxia inducible factor (HIF)-1-vascular endothelial growth factor, by inhibiting HIF-prolyl hydroxylase: A structural analysis of quercetin for inhibiting HIF-prolyl hydroxylase. Mol Pharmacol 71: 1676-1684.
10. Kicic A, Chua AC, Baker E,. 2001. Effect of iron chelators on proliferation and iron uptake in hepatoma cells. Cancer 92: 3093-3110.
11. Koivunen P, Hirsila M, Gunzler V, Kivirikko KI, Myllyharju J,. 2004. Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases. J Biol Chem 279: 9899-9904.
12. Lando D, Peet DJ, Gorman JJ, Whelan DA, Whitelaw ML, Bruick RK,. 2002a. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev 16: 1466-1471.
13. Lando D, Peet DJ, Whelan DA, Gorman JJ, Whitelaw ML,. 2002b. Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 295: 858-861.
14. Lee SH, Jeong Hee M, Eun Ah C, Ryu SE, Myung Kyu L,. 2008. Monoclonal antibody-based screening assay for factor inhibiting hypoxia-inducible factor inhibitors. J Biomol Screen 13: 494-503.
15. Lee YM, Lim JH, Chun YS, Moon HE, Lee MK, Huang LE, Park JW,. 2009. Nutlin-3, an Hdm2 antagonist, inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated inactivation of HIF-1alpha. Carcinogenesis 30: 1768-1775.
16. Leopoldini M, Russo N, Chiodo S, Toscano M,. 2006. Iron chelation by the powerful antioxidant flavonoid quercetin. J Agric Food Chem 54: 6343-6351.
17. Lloyd JB, Cable H, Rice-Evans C,. 1991. Evidence that desferrioxamine cannot enter cells by passive diffusion. Biochem Pharmacol 41: 1361-1363.
18. MacKenzie EL, Iwasaki K, Tsuji Y,. 2008. Intracellular iron transport and storage: From molecular mechanisms to health implications. Antioxid Redox Signal 10: 997-1030.
19. McDonough MA, McNeill LA, Tilliet M, Papamicael CA, Chen QY, Banerji B, Hewitson KS, Schofield CJ,. 2005. Selective inhibition of factor inhibiting hypoxia-inducible factor. J Am Chem Soc 127: 7680-7681.
20. McDonough MA, Li V, Flashman E, Chowdhury R, Mohr C, Lienard BM, Zondlo J, Oldham NJ, Clifton IJ, Lewis J, McNeill LA, Kurzeja RJ, Hewitson KS, Yang E, Jordan S, Syed RS, Schofield CJ,. 2006. Cellular oxygen sensing: Crystal structure of hypoxia-inducible factor prolyl hydroxylase (PHD2). Proc Natl Acad Sci USA 103: 9814-9819.
21. Park SS, Bae I, Lee YJ,. 2008. Flavonoids-induced accumulation of hypoxia-inducible factor (HIF)-1alpha/2alpha is mediated through chelation of iron. J Cell Biochem 103: 1989-1998.
22. Pouyssegur J, Dayan F, Mazure NM,. 2006. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441: 437-443.
23. Semenza GL,. 2003. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3: 721-732.
24. Shin DH, Chun YS, Lee DS, Huang LE, Park JW,. 2008. Bortezomib inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated repression of hypoxia-inducible factor-1. Blood 111: 3131-3136.
25. Stolze IP, Tian YM, Appelhoff RJ, Turley H, Wykoff CC, Gleadle JM, Ratcliffe PJ,. 2004. Genetic analysis of the role of the asparaginyl hydroxylase factor inhibiting hypoxia-inducible factor (HIF) in regulating HIF transcriptional target genes. J Biol Chem 279: 42719-42725.
26. Tian YM, Yeoh KK, Lee MK, Eriksson T, Kessler BM, Kramer HB, Edelmann MJ, Willam C, Pugh CW, Schofield CJ, Ratcliffe PJ,. 2011. Differential sensitivity of hypoxia inducible factor hydroxylation sites to hypoxia and hydroxylase inhibitors. J Biol Chem 286: 13041-13051.
27. Triantafyllou A, Mylonis I, Simos G, Bonanou S, Tsakalof A,. 2008. Flavonoids induce HIF-1alpha but impair its nuclear accumulation and activity. Free Radic Biol Med 44: 657-670.
28. Welford RW, Schlemminger I, McNeill LA, Hewitson KS, Schofield CJ,. 2003. The selectivity and inhibition of AlkB. J Biol Chem 278: 10157-10161.
29. Yeo EJ, Ryu JH, Cho YS, Chun YS, Huang LE, Kim MS, Park JW,. 2006. Amphotericin B blunts erythropoietin response to hypoxia by reinforcing FIH-mediated repression of HIF-1. Blood 107: 916-923.